Research Progress on Prevention and Treatment of Ototoxicity Associated with Nasopharyngeal Carcinoma Treatment

Nasopharyngeal Carcinoma (NPC) stands as one of the most prevalent malignant tumors in East and Southeast Asia. Radiotherapy and chemotherapy play vital roles in its treatment. With improved prognosis and significantly extended survival time, the attention toward treatment-associated ototoxicity is escalating. This article delineates the mechanisms of ototoxicity induced by radiotherapy and chemotherapy in nasopharyngeal carcinoma treatment. Furthermore, it discusses the strategies for preventing and treating ototoxicity in this context, intending to increase awareness and minimize its occurrence.